Epigenomics has named Richard Wender to the company’s medical advisory board for colorectal cancer screening.
Interleukin Genetics has appointed Lewis Bender to the post of CEO. Bender has been involved in biotechnology for over 15 years as a senior executive, including holding the post of senior VP of business development and VP of manufacturing and CTO at Emisphere Technologies.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
